Yunfeng Financial Group (SEHK:376) is back on investor radars after reporting half year earnings on 28 August 2026. The group reported net income of HK$632.2 million and basic earnings per share of HK$0.16 from continuing operations.
Yunfeng Financial Group’s latest earnings have arrived after a volatile period for the stock, with the share price up 6.56% in the last session and showing a 30-day share price return of 26.09%. However, it is still down 38.67% year to date and has produced a 1-year total shareholder return decline of 44.69%, while the 3-year total shareholder return of 84.55% points to a very different longer term picture of shifting sentiment and risk appetite.
Capitalize on Yunfeng Financial Group’s earnings momentum by lining it up against a curated set of 257 high quality undervalued stocks that combine solid cash flows with balance sheet strength.Bulls point to Yunfeng Financial Group’s higher half year earnings and strong 3 year total return, while bears highlight the steep 1 year slide. Which side does the current valuation and cash generation profile support next?
On a simple snapshot, Yunfeng Financial Group trades at a P/E of 12.6x, which looks expensive compared with both its peers and the wider Asian insurance sector.
The P/E ratio compares the company’s share price with its earnings per share. For an insurance stock like Yunfeng Financial Group, it gives a quick sense of how much investors are paying for each dollar of current earnings.
Based on the available data, Yunfeng Financial Group is described as expensive on this measure. Its 12.6x P/E is higher than the peer average of 7.2x, which suggests investors are currently paying a richer price for its earnings than for similar companies. Without forward forecasts, it is not clear whether this reflects confidence in future profit trends or simply a premium that may be hard to justify if earnings growth slows.
Compared with the broader Asian insurance industry, the picture is similar. The company’s 12.6x P/E is above the industry average of 11.2x, which again signals that investors are assigning a higher multiple than they are to the sector overall. This premium stands out even more given the lack of clear evidence on future revenue or earnings growth expectations in the data provided.
See what the numbers say about this price — find out in our valuation breakdown.
Result: Price-to-Earnings of 12.6x (OVERVALUED)
However, Yunfeng Financial Group still faces risks if earnings momentum stalls or insurance margins tighten, especially given its recent one-year and year-to-date share price declines.
Find out about the key risks to this Yunfeng Financial Group narrative.
While Yunfeng Financial Group screens as expensive on a simple P/E comparison, the SWS DCF model points the other way. At a share price of HK$2.03, the stock is assessed as trading above an estimated future cash flow value of HK$1.18, which frames it as overvalued on this second lens as well. If both earnings and cash flow checks lean to the same conclusion, where might more optimistic investors expect upside to come from next?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Yunfeng Financial Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 257 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
If this Yunfeng Financial Group earnings story feels mixed, you may want to quickly review the potential upside drivers for yourself by looking at the 1 key reward.
If Yunfeng Financial Group has sharpened your focus, do not stop here. The right mix of quality, value, and resilience often sits in plain sight.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com